Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Molecular Therapy. Oncology|January 15, 2025
FOXJ3, a novel tumor suppressor in neuroblastomaKishore B Challagundla, Anup S Pathania, Haritha Chava, et al.Cell Death & Disease|June 18, 2024
The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastomaAnup S Pathania, Haritha Chava, Nagendra K Chaturvedi, et al.Seminars in Cancer Biology|April 28, 2021
The emerging role of non-coding RNAs in the epigenetic regulation of pediatric cancersAnup S Pathania, Philip Prathipati, Manoj K Pandey, et al.Molecular Therapy. Nucleic Acids|May 31, 2024
SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastomaPhilip Prathipati, Anup S Pathania, Nagendra K Chaturvedi, et al.Cancers|September 15, 2020
Amino Acids Regulate Cisplatin Insensitivity in NeuroblastomaVenugopal Gunda, Anup S Pathania, Srinivas Chava, et al.Molecular Aspects of Medicine|October 19, 2019
The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: Challenges and opportunitiesNithya Mudgapalli, Palanisamy Nallasamy, Haritha Chava, et al.Journal of Natural Products|September 18, 2013
Semisynthesis of mallotus B from rottlerin: evaluation of cytotoxicity and apoptosis-inducing activityShreyans K Jain, Anup S Pathania, Samdarshi Meena, et al.Molecular Oncology|October 23, 2019
miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastomaSrinivas Chava, C Patrick Reynolds, Anup S Pathania, et al.Plos One|November 11, 2014
The synthetic tryptanthrin analogue suppresses STAT3 signaling and induces caspase dependent apoptosis via ERK up regulation in human leukemia HL-60 cellsAnup S Pathania, Suresh Kumar, Santosh K Guru, et al.Seminars in Cancer Biology|July 5, 2022
Immune checkpoint molecules in neuroblastoma: A clinical perspectiveAnup S Pathania, Philip Prathipati, Swati P Murakonda, et al.Pageof 3